日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

登録内容を編集ファイル形式で保存
 
 
ダウンロード電子メール
  Copy number variations of chromosome 16p13.1 region associated with schizophrenia

Ingason, A., Rujescu, D., Cichon, S., Sigurdsson, E., Sigmundsson, T., Pietilainen, O. P. H., Buizer-Voskamp, J. E., Strengman, E., Francks, C., Muglia, P., Gylfason, A., Gustafsson, O., Olason, P. I., Steinberg, S., Hansen, T., Jakobsen, K. D., Rasmussen, H. B., Giegling, I., Möller, H.-J., Hartmann, A., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Bramon, E., Kiemeney, L. A., Franke, B., Murray, R., Vassos, E., Toulopoulou, T., Mühleisen, T. W., Tosato, S., Ruggeri, M., Djurovic, S., Andreassen, O. A., Zhang, Z., Werge, T., Ophoff, R. A., Rietschel, M., Nöthen, M. M., Petursson, H., Stefansson, H., Peltonen, L., Collier, D., Stefansson, K., & St Clair, D. M. (2011). Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Molecular Psychiatry, 16, 17-25. doi:10.1038/mp.2009.101.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文

ファイル

表示: ファイル
非表示: ファイル
:
Ingason_et_al_Moleculair_Psychiatry_2011.pdf (出版社版), 596KB
ファイルのパーマリンク:
https://hdl.handle.net/21.11116/0000-0003-4A54-C
ファイル名:
Ingason_et_al_Moleculair_Psychiatry_2011.pdf
説明:
-
OA-Status:
閲覧制限:
公開
MIMEタイプ / チェックサム:
application/pdf / [MD5]
技術的なメタデータ:
著作権日付:
-
著作権情報:
-
CCライセンス:
-

作成者

表示:
非表示:
 作成者:
Ingason, A.1, 2, 著者
Rujescu, D.3, 著者
Cichon, S.4, 5, 著者
Sigurdsson, E.6, 著者
Sigmundsson, T.6, 著者
Pietilainen, O. P. H.7, 著者
Buizer-Voskamp, J. E.8, 9, 著者
Strengman, E.9, 著者
Francks, Clyde10, 11, 著者           
Muglia, P.10, 著者
Gylfason, A.1, 著者
Gustafsson, O.1, 著者
Olason, P. I.1, 著者
Steinberg, S.1, 著者
Hansen, T.2, 著者
Jakobsen, K. D.2, 著者
Rasmussen, H. B.2, 著者
Giegling, I.3, 著者
Möller, H-J 3, 著者
Hartmann, A.3, 著者
Crombie, C.12, 著者Fraser, G.12, 著者Walker, N.13, 著者Lonnqvist, J.14, 著者Suvisaari, J.14, 著者Tuulio-Henriksson, A.14, 著者Bramon, E.15, 著者Kiemeney, L. A.16, 著者Franke, B.17, 著者Murray, R.15, 著者Vassos, E.15, 著者Toulopoulou, T.15, 著者Mühleisen, T. W.4, 著者Tosato, S.18, 著者Ruggeri, M.18, 著者Djurovic, S.19, 20, 著者Andreassen, O. A.19, 20, 著者Zhang, Z.21, 著者Werge, T.2, 著者Ophoff, R. A.9, 22, 著者Rietschel, M.23, 著者Nöthen, M. M.4, 5, 著者Petursson, H.6, 著者Stefansson, H.1, 著者Peltonen, L.7, 24, 25, 著者Collier, D.15, 著者Stefansson, K.1, 著者St Clair, D. M. 12, 著者 全て表示
所属:
1deCODE genetics, Reykjavík, Iceland, ou_persistent22              
2Research Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen University Hospital, Roskilde, Denmark, ou_persistent22              
3Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig-Maximilians-University and Genetics Research Centre GmbH, Munich, Germany, ou_persistent22              
4Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany, ou_persistent22              
5Institute of Human Genetics, University of Bonn, Bonn, Germany, ou_persistent22              
6Department of Psychiatry, National University Hospital, Reykjavík, Iceland, ou_persistent22              
7Department for Molecular Medicine, National Public Health Institute, Helsinki, Finland, ou_persistent22              
8Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands, ou_persistent22              
9Department of Medical Genetics and Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands, ou_persistent22              
10Medical Genetics, GlaxoSmithKline R&D, Verona, Italy, ou_persistent22              
11Imaging Genomics, MPI for Psycholinguistics, Max Planck Society, Wundtlaan 1, 6525 XD Nijmegen, NL, ou_2579692              
12Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, ou_persistent22              
13Ravenscraig Hospital, Greenock, Scotland, ou_persistent22              
14Department of Mental Health and Addiction, National Public Health Institute, Helsinki, Finland, ou_persistent22              
15Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London, UK, ou_persistent22              
16Department of Epidemiology & Biostatistics (133 EPIB)/Department of Urology (659 URO), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, ou_persistent22              
17Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, ou_persistent22              
18Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy, ou_persistent22              
19Institute of Psychiatry, University of Oslo, Oslo, Norway, ou_persistent22              
20Departments of Medical Genetics and Psychiatry, Ulleval University Hospital, Oslo, Norway, ou_persistent22              
21Department of Statistics, UCLA, Los Angeles, CA, USA, ou_persistent22              
22UCLA Center for Neurobehavioral Genetics and Department of Human Genetics, Los Angeles, CA, USA, ou_persistent22              
23Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health Mannheim, University of Heidelberg, Mannheim, Germany, ou_persistent22              
24Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, ou_persistent22              
25The Broad Institute, Cambridge, MA, USA, ou_persistent22              

内容説明

表示:
非表示:
キーワード: -
 要旨: Deletions and reciprocal duplications of the chromosome 16p13.1 region have recently been reported in several cases of autism and mental retardation (MR). As genomic copy number variants found in these two disorders may also associate with schizophrenia, we examined 4345 schizophrenia patients and 35 079 controls from 8 European populations for duplications and deletions at the 16p13.1 locus, using microarray data. We found a threefold excess of duplications and deletions in schizophrenia cases compared with controls, with duplications present in 0.30% of cases versus 0.09% of controls (P=0.007) and deletions in 0.12 % of cases and 0.04% of controls (P>0.05). The region can be divided into three intervals defined by flanking low copy repeats. Duplications spanning intervals I and II showed the most significant (P=0.00010) association with schizophrenia. The age of onset in duplication and deletion carriers among cases ranged from 12 to 35 years, and the majority were males with a family history of psychiatric disorders. In a single Icelandic family, a duplication spanning intervals I and II was present in two cases of schizophrenia, and individual cases of alcoholism, attention deficit hyperactivity disorder and dyslexia. Candidate genes in the region include NTAN1 and NDE1. We conclude that duplications and perhaps also deletions of chromosome 16p13.1, previously reported to be associated with autism and MR, also confer risk of schizophrenia.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 20092011
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): PMID: 19786961
DOI: 10.1038/mp.2009.101
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Molecular Psychiatry
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: Nature Group
ページ: - 巻号: 16 通巻号: - 開始・終了ページ: 17 - 25 識別子(ISBN, ISSN, DOIなど): その他: 954925619131
その他: 1359-4184
CoNE: https://pure.mpg.de/cone/journals/resource/954925619131